Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Nazmul Islam, Colleen Lau, Alan Leeb, Deborah Mills & Luis Furuya-Kanamori. (2022) Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Alain Bouckenooghe, Fabrice Bailleux & Emmanuel Feroldi. (2019) Modeling the long-term persistence of neutralizing antibody in children and toddlers after vaccination with live attenuated Japanese encephalitis chimeric virus vaccine. Human Vaccines & Immunotherapeutics 15:1, pages 72-79.
Read now
Read now
Luisa Barzon & Giorgio Palù. (2018) Recent developments in vaccines and biological therapies against Japanese encephalitis virus. Expert Opinion on Biological Therapy 18:8, pages 851-864.
Read now
Read now
Nagendra R. Hegde & Milind M. Gore. (2017) Japanese encephalitis vaccines: Immunogenicity, protective efficacy, effectiveness, and impact on the burden of disease. Human Vaccines & Immunotherapeutics 13:6, pages 1320-1337.
Read now
Read now
K Chokephaibulkit, G Houillon, E Feroldi & A Bouckenooghe. (2016) Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV®) in children. Expert Review of Vaccines 15:2, pages 153-166.
Read now
Read now
Xing Li, Shu-Juan Ma, Xie Liu, Li-Na Jiang, Jun-Hua Zhou, Yi-Quan Xiong, Hong Ding & Qing Chen. (2014) Immunogenicity and safety of currently available Japanese encephalitis vaccines: A systematic review. Human Vaccines & Immunotherapeutics 10:12, pages 3579-3593.
Read now
Read now
Tomohiro Ishikawa & Eiji Konishi. (2014) Japanese encephalitis: epidemiology, prevention and current status of antiviral drug development. Expert Opinion on Orphan Drugs 2:9, pages 923-936.
Read now
Read now
Suzanne M Shepherd & William H Shoff. (2014) Vaccination for the expatriate and long-term traveler. Expert Review of Vaccines 13:6, pages 775-800.
Read now
Read now
Myrna C Bonaldo, Patrícia C Sequeira & Ricardo Galler. (2014) The yellow fever 17D virus as a platform for new live attenuated vaccines. Human Vaccines & Immunotherapeutics 10:5, pages 1256-1265.
Read now
Read now
Sang-Im Yun & Young-Min Lee. (2014) Japanese encephalitis. Human Vaccines & Immunotherapeutics 10:2, pages 263-279.
Read now
Read now
Lin H Chen, Karin Leder & Mary E Wilson. (2013) Business travelers: vaccination considerations for this population. Expert Review of Vaccines 12:4, pages 453-466.
Read now
Read now
Mohan Babu Appaiahgari & Sudhanshu Vrati. (2012) Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV). Expert Opinion on Biological Therapy 12:9, pages 1251-1263.
Read now
Read now
Lin H Chen, David R Hill & Annelies Wilder-Smith. (2011) Vaccination of travelers: how far have we come and where are we going?. Expert Review of Vaccines 10:11, pages 1609-1620.
Read now
Read now
Scott B Halstead & Stephen J Thomas. (2011) New Japanese encephalitis vaccines: alternatives to production in mouse brain. Expert Review of Vaccines 10:3, pages 355-364.
Read now
Read now
Articles from other publishers (25)
Punyisa Asawapaithulsert, Thundon Ngamprasertchai & Amornphat Kitro. (2023) Japanese Encephalitis Vaccine Acceptance and Strategies for Travelers: Insights from a Scoping Review and Practitioners in Endemic Countries. Vaccines 11:11, pages 1683.
Crossref
Crossref
Luis Furuya-Kanamori, Narayan Gyawali, Deborah J Mills, Christine Mills, Leon E Hugo, Gregor J Devine & Colleen L Lau. (2023) Immunogenicity of a single fractional intradermal dose of Japanese encephalitis live attenuated chimeric vaccine. Journal of Travel Medicine 30:2.
Crossref
Crossref
Scott B. Halstead, Susan L. Hills, Anthony A. Marfin & Tom Solomon. 2023. Plotkin's Vaccines. Plotkin's Vaccines
577
607.e11
.
John Aaskov. 2023. History of Arbovirology: Memories from the Field. History of Arbovirology: Memories from the Field
115
158
.
Sanjay Kumar, Akanksha Verma, Pardeep Yadav, Sumit Kumar Dubey, Esam Ibraheem Azhar, S. S. Maitra & Vivek Dhar Dwivedi. (2022) Molecular pathogenesis of Japanese encephalitis and possible therapeutic strategies. Archives of Virology 167:9, pages 1739-1762.
Crossref
Crossref
Naina McCann, Daniel O’Connor, Teresa Lambe & Andrew J Pollard. (2022) Viral vector vaccines. Current Opinion in Immunology 77, pages 102210.
Crossref
Crossref
Nazmul Islam, Chang Xu, Colleen L. Lau, Deborah J. Mills, Justin Clark, Gregor J. Devine, Leon E. Hugo, Narayan Gyawali, Lukman Thalib & Luis Furuya-Kanamori. (2022) Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis. Vaccine 40:26, pages 3546-3555.
Crossref
Crossref
Luis Furuya-Kanamori, Chang Xu, Suhail A.R. Doi, Justin Clark, Kinley Wangdi, Deborah J. Mills & Colleen L. Lau. (2021) Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis. Vaccine 39:32, pages 4429-4436.
Crossref
Crossref
Hee-Jung Lee, Hanul Choi, Ki Hoon Park, Yuyeon Jang, Young-jin Hong & Young Bong Kim. (2020) Retention of neutralizing antibodies to Japanese encephalitis vaccine in age groups above fifteen years in Korea. International Journal of Infectious Diseases 100, pages 53-58.
Crossref
Crossref
Sheila M. Mackell & Mike Starr. 2019. Travel Medicine. Travel Medicine
125
136
.
Joseph Torresi & Herwig Kollaritsch. 2019. Travel Medicine. Travel Medicine
101
124
.
Joseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine GibneyJoseph Torresi, Sarah McGuinness, Karin Leder, Daniel O’Brien, Tilman Ruff, Mike Starr & Katherine Gibney. 2019. Manual of Travel Medicine. Manual of Travel Medicine
19
169
.
Devi Shankar Suman, Kshitij Chandel, Ary Faraji, Randy Gaugler & Kailash Chandra. 2018. Mosquito-borne Diseases. Mosquito-borne Diseases
235
279
.
Pope Kosalaraksa, Veerachai Watanaveeradej, Chitsanu Pancharoen, Maria Rosario Capeding, Emmanuel Feroldi & Alain Bouckenooghe. (2017) Long-term Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine in Toddlers and Booster Response 5 Years After Primary Immunization. Pediatric Infectious Disease Journal 36:4, pages e108-e113.
Crossref
Crossref
Sirintip Sricharoenchai, Keswadee Lapphra, Sunate Chuenkitmongkol, Wanatpreeya Phongsamart, Alain Bouckenooghe, Orasri Wittawatmongkol, Supattra Rungmaitree & Kulkanya Chokephaibulkit. (2017) Immunogenicity of a Live Attenuated Chimeric Japanese Encephalitis Vaccine as a Booster Dose After Primary Vaccination With Live Attenuated SA14-14-2 Vaccine. Pediatric Infectious Disease Journal 36:2, pages e45-e47.
Crossref
Crossref
Pakpoom Janewongwirot, Thanyawee Puthanakit, Suvaporn Anugulruengkitt, Watsamon Jantarabenjakul, Chayapa Phasomsap, Sompong Chumket, Sutee Yoksan & Chitsanu Pancharoen. (2016) Immunogenicity of a Japanese encephalitis chimeric virus vaccine as a booster dose after primary vaccination with SA14-14-2 vaccine in Thai children. Vaccine 34:44, pages 5279-5283.
Crossref
Crossref
Stephen J. Thomas, Timothy P. Endy, Alan L. Rothman & Alan D. Barrett. 2015. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
1881
1903.e6
.
Gustavo Dayan, Konstantin Pugachev, Joan Bevilacqua, Jean Lang & Thomas Monath. (2013) Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus. Viruses 5:12, pages 3048-3070.
Crossref
Crossref
Ruth Chin & Joseph Torresi. (2013) Japanese B Encephalitis: An Overview of the Disease and Use of Chimerivax-JE as a Preventative Vaccine. Infectious Diseases and Therapy 2:2, pages 145-158.
Crossref
Crossref
Ravi Kant Upadhyay. (2013) Japanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses. ISRN Virology 2013, pages 1-24.
Crossref
Crossref
Elina O. Erra, Helena Hervius Askling, Sutee Yoksan, Lars Rombo, Jukka Riutta, Sirkka Vene, Lars Lindquist, Olli Vapalahti & Anu Kantele. (2013) Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes. Clinical Infectious Diseases 56:2, pages 267-270.
Crossref
Crossref
Joseph Torresi & Herwig Kollaritsch. 2013. Travel Medicine. Travel Medicine
101
123
.
Kamal Desai, L. Coudeville & F. Bailleux. (2012) Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine. Vaccine 30:15, pages 2510-2515.
Crossref
Crossref
K. Leder, L.H. Chen & M.E. Wilson. (2012) Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis. Vaccine 30:15, pages 2600-2604.
Crossref
Crossref
Charung Muangchana, Narong Henprasertthae, Krissana Nurach, Kesorn Theppang, Pornsak Yoocharoen, Porpit Varinsathien, Sirirat Techathawat, Somboon Sanohsieng & Surapee Anantapreecha. (2012) Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study. Vaccine 30:2, pages 361-367.
Crossref
Crossref